14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AQST vs AMD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Aquestive Therapeutics, Inc. (AQST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AQST carries a Unified Composite Score of 62.9/100 (BUY) at $3.46 (N/M Forward P/E, -114.1% operating margin), whereas AMD carries 62.6/100 (BUY) at $424.39 (24.1x Forward P/E, 17.8% operating margin).
Technical & Structure Timing Caution: AQST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.5); meanwhile AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Edge AI / Inference ChipsHardware-Agnostic ML CompilersInference Serving / Speculative DecodingKV-Cache / Attention Memory CompressionMixture-of-Experts / Sparse Models
Investor FAQ AQST vs AMD Key Questions & Quantitative Answers
As of Nov 20, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Aquestive Therapeutics, Inc. (AQST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AQST carries a Unified Composite Score of 62.9/100 (BUY) at $3.46 (N/M Forward P/E, -114.1% operating margin), whereas AMD carries 62.6/100 (BUY) at $424.39 (24.1x Forward P/E, 17.8% operating margin). Technical & Structure Timing Caution: AQST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.5); meanwhile AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AMD leads the Growth & Scale pillar: AQST posts -41.0% YoY revenue growth and +0.0% YoY earnings growth on $49M TTM revenue (65.3% gross margin, -114.1% operating margin), compared with AMD at +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AQST cumulative revenue shifted -42.9% while AMD shifted +435.4%. In operating R&D and SG&A reinvestment, AQST deploys N/A (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($17.4B) (7 disclosures) for AMD.
AMD screens cheaper on headline valuation multiples. AQST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 8.9x EV/Revenue (-83.3% FCF margin), whereas AMD trades at 24.1x Forward P/E, 104.5x Trailing P/E, 0.47x PEG, and 17.9x EV/Revenue (15.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AQST (0.0% ROE) versus AMD (12.0% ROE) capital efficiency.
In options market volatility and institutional positioning, AQST carries 87.9% implied volatility (64th %ile, Elevated (60th–80th %ile)), a 0.98x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.89β · 56% Vol realized risk). By comparison, AMD carries 87.2% implied volatility (11th %ile, Compressed (<25th %ile)), a 1.31x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.65β · 124% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.